Prosecution Insights
Last updated: October 25, 2026
Application No. 19/315,718

BONE FUSION DEVICE, APPARATUS AND METHOD

Non-Final OA §102§DP
Filed
Sep 01, 2025
Priority
Mar 15, 2013 — provisional 61/794,789 +6 more
Examiner
KU, SI MING
Art Unit
3775
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Neuropro Technologies Inc.
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
1y 11m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
567 granted / 779 resolved
+2.8% vs TC avg
Strong +33% interview lift
Without
With
+32.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
40 currently pending
Career history
826
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
38.5%
-1.5% vs TC avg
§102
25.6%
-14.4% vs TC avg
§112
26.3%
-13.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 779 resolved cases

Office Action

§102 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Status of the Claims This Office Action is responsive to the preliminary amendment filed September 1, 2025. As directed by the preliminary amendment: Claims 1-10 have been amended. Claims 11-20 have been cancelled. Claims 21-29 are newly added. Claims 1-10 and 21-29 are presently pending in this application. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “an extending mechanism coupled with a positioning element such that movement of the positioning element causes the extending mechanism to move with respect to the positioning element” in claim 21. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claim(s) 1, 2, 5, and 6 is/are rejected under pre-AIA 35 U.S.C. 102(b) as being anticipated by McLuen (US 7,727,280). Regarding claim 1, McLuen discloses a bone fusion device (1000’) (figures 14A and 14B) for insertion into a desired location (col. 11, ll. 64-67 and col. 12, ll. 1-26) comprising an extending mechanism (1002, 1010) including one or more extending blocks (1010) coupled with a positioning element (1002) such that movement of the positioning element (1002) causes the one or more extending blocks (1010) to move with respect to the positioning element (1002) (figures 14A and 14B), a first plate (1006’), and a second plate (another element 1006’), the first and second plates (elements 1006’) coupled with the one or more extending blocks (1010) (figures 14A and 14B) such that when the one or more extending blocks (1010) move with respect to the positioning element (1002), the first and second plates (elements 1006’) move along a path (figures 14A and 14B) with respect to each other between a retracted position (figure 14A) in which the first and second plates (elements 1006’) are adjacent to each other (figure 14A) to an extended position (figure 14B) in which the first and second plates (elements 1006’) are spread apart from each other (figure 14B), wherein a portion of the first plate (1006’) directly contacted by the one or more extending blocks (1010) (figures 14A and 14B) changes as the one or more extending blocks (1010) move with respect to the positioning element (1002) (figures 14A and 14B). Regarding claim 2, McLuen discloses wherein the first and second plates (elements 1006’) are sized such that an entirety of a perimeter of the first and second plates (elements 1006’) about the path (figures 14A and 14B) align with an outermost perimeter of the device (1000’) about the path (figures 14A and 14B). Regarding claim 5, McLuen discloses wherein the one or more extending blocks (1010) each comprise an angled surface (figures 14A and 14B) between a left side (figures 14A and 14B) and a right side (figures 14A and 14B), wherein the left sides of the one or more extending blocks (1010) are aligned with a left face of the first and second plates (elements 1006’) and the right sides of the one or more extending blocks (1010) are aligned with a right face of the first and second plates (elements 1006’). Regarding claim 6, McLuen discloses wherein the angled surface forms a continuous sheet between the left and right sides (figures 14A and 14B) of the one or more extending blocks (1010) in order to increase the surface area of the angled surface (figures 14A and 14B). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-10 and 21-29 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Patent No. 12,409,050. Although the claims at issue are not identical, they are not patentably distinct from each other because the difference between the application claims and the patent claims lies in the fact that the patent claims include more elements and are thus much specific. Thus the invention of the patent claims are in effect a “species” of the “generic” invention of the application claims. It has been held that the generic invention is “anticipated” by the “species”. Claims 21-29 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-14 of U.S. Patent No. 11,963,884. Although the claims at issue are not identical, they are not patentably distinct from each other because the difference between the application claims and the patent claims lies in the fact that the patent claims include more elements and are thus much specific. Thus the invention of the patent claims are in effect a “species” of the “generic” invention of the application claims. It has been held that the generic invention is “anticipated” by the “species”. Claims 1-10 rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-9 of U.S. Patent No. 11,399,956. Although the claims at issue are not identical, they are not patentably distinct from each other. For example, claim 1 of the instant application discloses all the features/elements of claim 1 of USP ‘956 such as an extending mechanism, a first plate, and a second plate. Yet, claim 1 of the instant application lacks one or more biasing elements. However, claim 3 of the instant application clearly contemplates this feature. Claims 21-29 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 10-19 of U.S. Patent No. 11,399,956. Although the claims at issue are not identical, they are not patentably distinct from each other because the difference between the application claims and the patent claims lies in the fact that the patent claims include more elements and are thus much specific. Thus the invention of the patent claims are in effect a “species” of the “generic” invention of the application claims. It has been held that the generic invention is “anticipated” by the “species”. Claims 1-10 and 21-29 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-11 of U.S. Patent No. 10,098,757. Although the claims at issue are not identical, they are not patentably distinct from each other because the difference between the application claims and the patent claims lies in the fact that the patent claims include more elements and are thus much specific. Thus the invention of the patent claims are in effect a “species” of the “generic” invention of the application claims. It has been held that the generic invention is “anticipated” by the “species”. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SI MING KU whose telephone number is (571)270-5450. The examiner can normally be reached Monday-Friday, 9:30am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Truong can be reached at (571)272-4705. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SI MING KU/Primary Examiner, Art Unit 3775
Read full office action

Prosecution Timeline

Sep 01, 2025
Application Filed
Jul 21, 2026
Non-Final Rejection mailed — §102, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12765881
Patient Specific Instrumentation For Surgical Implantation Of A Femoral Component
2y 2m to grant Granted Oct 20, 2026
Patent 12765985
A SURGICAL GUIDE
1y 11m to grant Granted Oct 20, 2026
Patent 12765916
MEDICAL DEVICE HAVING A ROTATABLE WORKING CHANNEL AND RELATED METHODS OF USE
1y 10m to grant Granted Oct 20, 2026
Patent 12765930
KIT FOR PRODUCING AND EXTRUDING BONE CEMENT, AND METHOD
1y 10m to grant Granted Oct 20, 2026
Patent 12765894
CHEVRON OSTEOTOMY TOOLS AND METHODS
1y 10m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+32.8%)
3y 1m (~1y 11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 779 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month